X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atrial fibrillation (250) 250
index medicus (219) 219
warfarin (207) 207
non-vitamin k antagonist oral anticoagulants (192) 192
humans (169) 169
anticoagulants (144) 144
cardiac & cardiovascular systems (135) 135
dabigatran (132) 132
stroke (122) 122
rivaroxaban (109) 109
administration, oral (93) 93
atrial fibrillation - drug therapy (84) 84
apixaban (77) 77
aged (74) 74
anticoagulants - administration & dosage (74) 74
stroke prevention (74) 74
anticoagulants - therapeutic use (72) 72
female (72) 72
male (72) 72
risk (71) 71
anticoagulation (69) 69
anticoagulants - adverse effects (66) 66
vitamin k antagonists (60) 60
edoxaban (56) 56
safety (56) 56
stroke - prevention & control (56) 56
non-vitamin k antagonist oral anticoagulant (55) 55
non-vitamin k oral anticoagulants (55) 55
oral anticoagulants (55) 55
atrial fibrillation - complications (54) 54
venous thromboembolism (51) 51
risk factors (50) 50
antithrombotic therapy (48) 48
bleeding (48) 48
peripheral vascular disease (48) 48
thromboembolism (48) 48
management (47) 47
therapy (46) 46
treatment outcome (45) 45
cardiology (44) 44
hemorrhage - chemically induced (44) 44
prevention (44) 44
middle aged (43) 43
efficacy (41) 41
medicine & public health (41) 41
aged, 80 and over (40) 40
hematology (40) 40
pharmacology & pharmacy (40) 40
cardiac arrhythmia (39) 39
medicine, general & internal (37) 37
vitamin k - antagonists & inhibitors (37) 37
atrial-fibrillation (36) 36
stroke - etiology (35) 35
vitamin k (33) 33
catheter ablation (29) 29
intracranial hemorrhage (29) 29
metaanalysis (28) 28
analysis (27) 27
review (27) 27
vitamin-k antagonists (27) 27
care and treatment (26) 26
internal medicine (26) 26
retrospective studies (26) 26
atrial fibrillation - diagnosis (25) 25
outcomes (25) 25
thromboembolism - prevention & control (25) 25
fibrillation (23) 23
oral anticoagulation (23) 23
drug therapy (22) 22
factor xa inhibitor (22) 22
mortality (22) 22
dabigatran - therapeutic use (21) 21
direct oral anticoagulants (21) 21
guidelines (21) 21
patients (21) 21
cardiovascular (20) 20
noacs (20) 20
nonvalvular atrial-fibrillation (20) 20
thrombosis (20) 20
warfarin - adverse effects (20) 20
dabigatran etexilate (19) 19
rivaroxaban - therapeutic use (19) 19
vitamin k antagonist (19) 19
abridged index medicus (18) 18
aspirin (18) 18
dosage and administration (18) 18
adherence (17) 17
atrial fibrillation - epidemiology (17) 17
cardioversion (17) 17
clinical trials (17) 17
dabigatran - adverse effects (17) 17
hemorrhage (17) 17
major bleeding (17) 17
atrial fibrillation - therapy (16) 16
clinical neurology (16) 16
medical research (16) 16
medicine (16) 16
medicine, experimental (16) 16
meta-analysis (16) 16
percutaneous coronary intervention (16) 16
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (379) 379
German (17) 17
Japanese (15) 15
Russian (4) 4
French (2) 2
Hungarian (2) 2
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 03/2017, Volume 135, Issue 10, pp. e604 - e633
Journal Article
Journal Article
EP Europace, ISSN 1099-5129, 08/2018, Volume 20, Issue 8, pp. 1231 - 1242
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 6, pp. 1113 - 1126
Summary Non-vitamin K antagonist oral anticoagulants (NOACs) are increasingly used in the prevention and treatment of venous thromboembolism and in the... 
Review Article | Bleeding management | Bleeding profiles | Reversal agent | Non-vitamin K oral anticoagulant | Real-world data | DABIGATRAN ANTICOAGULATION | STROKE PREVENTION | HEMOSTATIC AGENTS | real-world data | reversal agent | RANDOMIZED EVALUATION | bleeding management | non-vitamin K oral anticoagulant | INTRACRANIAL HEMORRHAGE | ACTIVATED FACTOR-VII | PROTHROMBIN COMPLEX CONCENTRATE | PERIPHERAL VASCULAR DISEASE | NONVALVULAR ATRIAL-FIBRILLATION | HEMATOLOGY | ACUTE VENOUS THROMBOEMBOLISM | ELDERLY-PATIENTS | Perioperative Care | Recombinant Proteins - therapeutic use | Meta-Analysis as Topic | Postoperative Hemorrhage - prevention & control | Humans | Clinical Protocols | Warfarin - adverse effects | Postoperative Hemorrhage - chemically induced | Vulnerable Populations | Antithrombins - pharmacokinetics | Thrombophilia - etiology | Neoplasms - complications | Clinical Trials, Phase III as Topic | Blood Transfusion | Drug Design | Retrospective Studies | Thrombophilia - drug therapy | Antidotes - chemistry | Risk Assessment | Hemorrhage - therapy | Antithrombins - therapeutic use | Atrial Fibrillation - complications | Factor Xa Inhibitors - pharmacokinetics | Randomized Controlled Trials as Topic | Factor Xa Inhibitors - therapeutic use | Intracranial Hemorrhages - therapy | Hemostatic Techniques | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Hemorrhages - chemically induced | Blood Coagulation Factors - therapeutic use | Kidney Failure, Chronic - complications | Aged | Disease Management | Hemorrhage - chemically induced | Antidotes - therapeutic use | Renal Dialysis
Journal Article
Stroke, ISSN 0039-2499, 06/2019, Volume 50, Issue 6, pp. 1480 - 1489
Journal Article
European Heart Journal, ISSN 0195-668X, 04/2018, Volume 39, Issue 16, pp. 1394 - 1403
Abstract Aims To evaluate the effect of telemonitoring on adherence to non-vitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF)... 
Adherence | Telemonitoring | Atrial fibrillation | Non-Vitamin K antagonist oral anticoagulants | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MANAGEMENT | PERSISTENCE | RISK | REGIMENS | STROKE | IMPACT | THERAPY | Non-vitamin K antagonist oral anticoagulants | MEDICATION ADHERENCE
Journal Article
Journal Article